![Edward Sturchio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Edward Sturchio is General Counsel at Immatics NV since 2020.
Formerly, Mr. Sturchio was Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
Mr. Sturchio completed undergraduate studies at Villanova University and graduate studies at Seton Hall University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMATICS N.V. | Consejero General | 01/06/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Consejero General | 01/02/2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Consejero General | 01/08/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
Seton Hall University School of Law
 Seton Hall University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
